palmidrol has been researched along with Breast Cancer in 3 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " anandamide (arachidonoylethanolamide, AEA), 2-arachidonoylglycerol (2-AG) and palmitoylethanolamide (PEA), in the control of inflammation and of the proliferation of tumor cells is reviewed here." | 4.80 | Cannabimimetic fatty acid derivatives in cancer and inflammation. ( Bisogno, T; De Petrocellis, L; Di Marzo, V; Melck, D, 2000) |
| "Indeed, long-term treatment of human breast cancer cells (HBCCs) with PEA downregulates the expression of the enzyme responsible for AEA degradation, the fatty acid amide hydrolase, thereby leading to an enhancement of AEA-induced, and cannabinoid CB1 receptor-mediated, cytostatic effect on HBCCs." | 1.31 | Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems. ( Bifulco, M; Bisogno, T; De Petrocellis, L; Di Marzo, V; Ligresti, A; Melck, D, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Petrocellis, L | 3 |
| Bisogno, T | 3 |
| Ligresti, A | 1 |
| Bifulco, M | 2 |
| Melck, D | 3 |
| Di Marzo, V | 3 |
| Orlando, P | 1 |
| Zagoory, O | 1 |
| Vogel, Z | 1 |
1 review available for palmidrol and Breast Cancer
| Article | Year |
|---|---|
Cannabimimetic fatty acid derivatives in cancer and inflammation.
Topics: Adjuvants, Immunologic; Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Age | 2000 |
2 other studies available for palmidrol and Breast Cancer
| Article | Year |
|---|---|
Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
Topics: Amides; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Breast Neoplasms; Cannabinoi | 2002 |
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Ar | 2001 |